Tickers

1. Composite Trajectory Verdict

All three statements carry roughly equal weight because UAA's performance depends on revenue and margin trends (income statement), ability to fund operations and restructuring (cash flow), and leverage/equity capacity (balance sheet).

Composite Trajectory: Deteriorating

Annual revenue has declined for three consecutive years (FY2024 $5.70B → FY2025 $5.16B → FY2026 $4.97B), gross margin compressed 240 bps in FY2026 to 45.5%, operating losses persisted, and net loss widened to $495.6M due to a $294.8M tax expense from valuation allowances. Operating cash flow remained negative for two years (-$59.3M FY2025, -$75.1M FY2026). Total debt rose to $1.19B from $595M, while equity fell to $1.41B from $1.89B. The Q1 FY2027 improvement in gross margin (+590 bps) and operating income was driven by a ~$70M one-time tariff refund benefit, not sustainable core improvement.

2. Red Flags

• Valuation allowance on U.S. federal deferred tax assets increased to $644.4M at March 31, 2026 from $292.4M a year earlier, generating a $294.8M tax expense despite a pre-tax loss (10-K FY2026, Note 15).
• Restructuring plan expanded to $305M (from ~$255M) with $260.7M already incurred; charges are recurring across FY2025 and FY2026 (10-K FY2026, MD&A and Note 11).
• Litigation reserve of $98.5M recorded in FY2026 for insurance carrier dispute, with $90M paid (10-K FY2026, Note 8).
• Operating cash flow negative for two consecutive fiscal years (-$59.3M FY2025, -$75.1M FY2026) vs. +$354.0M in FY2024 (10-K FY2026, Statements of Cash Flows).
• Total debt increased to $1.19B at March 31, 2026 from $595M a year earlier, including $400M of new 7.25% Senior Notes due 2030; interest expense rose to $30.3M from $6.1M (10-K FY2026, Note 7).
• Credit facility covenants amended in August 2026 to lower interest coverage requirement (3.00x from 3.50x) and raise leverage limit (3.75x from 3.25x) (10-Q Q1 FY2027, Capital Resources).
• Share repurchases continued ($25M in FY2026, $90M in FY2025) despite negative net income and negative operating cash flow (10-K FY2026, Note 9).
• Gross margin decline of 240 bps in FY2026 attributed 155 bps to tariff impacts (10-K FY2026, MD&A).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Overall Assessment: Net revenues have fallen for three straight years, from $5.70B in FY2024 to $5.16B in FY2025 (-9.4%) to $4.97B in FY2026 (-3.8%) (10-K FY2026, Statements of Operations). Gross margin peaked at 47.9% in FY2025 then dropped to 45.5% in FY2026, a 240 bps decline driven by 155 bps of tariff impact (10-K FY2026, MD&A). SG&A decreased 11.8% in FY2026 to $2.29B after rising in FY2025, but restructuring charges more than doubled to $127.7M (10-K FY2026, Statements of Operations). Operating loss narrowed slightly to -$163.1M from -$185.2M, yet net loss more than doubled to -$495.6M from -$201.3M due to a $294.8M income tax expense from valuation allowances (10-K FY2026, Statements of Operations and Note 15). Quarterly Q1 FY2027 vs Q1 FY2026 showed revenue down 3.2% but gross margin up 590 bps to 54.1% and operating income of $46.7M vs $3.3M, entirely due to a ~$70M tariff refund benefit recognized in cost of goods sold (10-Q Q1 FY2027, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Overall Assessment: Operating cash flow has been negative for two consecutive fiscal years: -$59.3M in FY2025 and -$75.1M in FY2026, a sharp reversal from +$354.0M in FY2024 (10-K FY2026, Statements of Cash Flows). Free cash flow (operating cash flow less capex) was -$162.2M in FY2026 and -$228.0M in FY2025. Investing cash flow swung to -$688.8M in FY2026 due to a $601.2M restricted investment deposit for the Senior Notes due 2026 defeasance (10-K FY2026, Statements of Cash Flows). Financing cash flow turned positive at $560.6M in FY2026 from -$180.8M in FY2025, funded by $400M Senior Notes due 2030 issuance and $490M revolver borrowings (10-K FY2026, Statements of Cash Flows). In Q1 FY2027, operating cash flow improved to $109.1M from $48.9M in Q1 FY2026, and investing cash flow was +$585.4M from restricted investment maturities, but financing cash flow was -$607.1M due to the $600M Senior Notes due 2026 settlement (10-Q Q1 FY2027, Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Overall Assessment: Total stockholders' equity declined from $2.15B at March 31, 2024 to $1.89B at March 31, 2025 to $1.41B at March 31, 2026, driven by cumulative net losses and share repurchases (10-K FY2026, Statements of Stockholders' Equity). Cash and cash equivalents fell to $309.2M from $501.4M, though $605.4M of restricted investments were held for the defeased Senior Notes due 2026 (10-K FY2026, Balance Sheets). Total debt (current + non-current) rose to $1.19B from $595.1M, reflecting the new 7.25% Senior Notes due 2030 and $200M revolver balance (10-K FY2026, Note 7). Current liabilities jumped to $1.68B from $1.11B due to the $599.8M current maturity of the defeased Senior Notes due 2026 (10-K FY2026, Balance Sheets). As of June 30, 2026, cash increased to $396.0M and the Senior Notes due 2026 were settled, reducing current debt (10-Q Q1 FY2027, Balance Sheets).

6. Data Gaps

• Quarterly income statement, cash flow, and balance sheet data for Q2, Q3, and Q4 of FY2026 and FY2025 (only Q1 FY2026 and Q1 FY2027 are provided in the 10-Q filings).
• Full FY2024 balance sheet details (only equity and cash flow beginning balances are shown).
• EBITDA and covenant compliance metrics (consolidated EBITDA, interest expense) for each period to assess leverage and coverage trends.
• Segment-level quarterly revenue and operating income for periods beyond the annual segment disclosure.
• Breakdown of "Other segment expenses" in Corporate Other for quarterly periods.
• Details on the $70M tariff refund benefit timing and sustainability beyond Q1 FY2027.